Moxidectin: A review of chemistry, pharmacokinetics and use in horses

Parasites and Vectors

Volumn 2, Issue SUPPL. 2, 2009, Pages

  Cobb, Rami ^a   Boeckh, Albert ^a  

^a ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; FENBENDAZOLE; GLUTAMIC ACID; GLYCOPROTEIN P; IVERMECTIN; MILBEMYCIN; MOXIDECTIN; MOXIDECTIN PLUS PRAZIQUANTEL; PRAZIQUANTEL; QUEST; UNCLASSIFIED DRUG; VETERINARY DRUG;

ANOPLOCEPHALA; ANTHELMINTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CESTODE; CESTODIASIS; CYATHOSTOMINOSIS; CYATHOSTOMUM; CYST (RESTING STAGE); DIROFILARIASIS; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TRANSPORT; FECES ANALYSIS; HAEMONCHOSIS; HAEMONCHUS CONTORTUS; HELMINTHIASIS; HORSE; LARVA; MAXIMUM PLASMA CONCENTRATION; NEMATODE; NEMATODIASIS; NEUROTOXICITY; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASCARIS EQUORUM; PREGNANCY; SINGLE DRUG DOSE; STRONGYLOIDES; STRONGYLOIDES WESTERI; STRONGYLOIDIASIS; STRUCTURE ACTIVITY RELATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

CESTODA; EQUIDAE; NEMATODA;

EID: 70349792647     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-2-S2-S5     Document Type: Article

References (64)

1. Structure and activity of avermectins and milbemycins in animal health. WL Shoop H Mrozik MH Fisher, Vet Parasitol 1995 59 139 56 10.1016/0304-4017(94) 00743-V 7483237
2. A dopamine-gated ion channel (HcGGR3*) from Haemonchus contortus is expressed in the cervical papillae and is associated with macrocyclic lactone resistance. V Rao SZ Siddiqui RK Prichard SG Forrester, Molecular & Biochemical Parasitology 2009 166 54 61 10.1016/j.molbiopara.2009.02.011
3. Haemonchus contortus: Effects of glutamate, ivermectin, and moxidectin on inulin uptake activity in unselected and ivermectin-selected adults. J-P Paiement C Leger P Ribeiro RK Prichard, Experimental Parasitology 1999 92 193 198 10.1006/expr.1999.4413 10403760
4. Interaction of MLs with P-glycoprotein: Structure-affinity relationship. A Lespine S Martin J Dupuy A Roulet T Pineau S Orlowski M Alvinerie, Eur J Pharma Sc 2007 30 84 94 10.1016/j.ejps.2006.10.004 (Pubitemid 44908930)
5. Interaction of ivermectin with multidrug resistance proteins (MRP1,2 and 3). A Lespine J Dupuy S Orlowski T Nagy H Glavinas P Krajcsi M Alvinerie, Chemico-Biol Interactions 2006 159 169 179 10.1016/j.cbi.2005.11.002 (Pubitemid 43112427)
6. Therapeutic implications of the MDR-1 gene. KL Mealey, J Vet Pharmacol Therap 2004 27 257 64 10.1111/j.1365-2885.2004.00607.x (Pubitemid 39482230)
7. Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of Collies from the Northwestern United States. KL Mealey S Bentjen D Waiting, AJVR 2002 63 479 481 10.2460/ajvr.2002. 63.479
8. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. J Griffin N Fletcher R Clemence S Blanchflower DJ Brayden, JVPT 2005 28 257 265 10.1111/j.1365-2885.2005.00655.x (Pubitemid 40896881)
9. Safety of moxidectin in avermectin-sensitive Collies. A Paul W Tranquilli D Hutchens, AJVR 2000 61 482 483 10.2460/ajvr.2000.61.482
10. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. WJ Blackhall HY Liu M Xu RK Prichard RN Beech, Mol Biochem Parasitol 1998 95 193 201 10.1016/S0166-6851(98)00087-5 9803412
11. Effects of the multi-drug reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). M Molento R Prichard, Parasitol Res 1999 85 1007 1011 10.1007/s004360050673 10599924
12. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. M Xu M Molento W Blackhall P Ribeiro R Beech R Prichard, Mol Biochem Parasitol 1998 91 327 335 10.1016/S0166-6851(97)00215-6 9566525
13. Moxidectin: Metabolic fate and blood pharmacokinetics of 14C-labeled moxidectin in horses. J Afzal A Burke P Batten R DeLay P Miller, J Agric Food Chem 1997 45 3627 3633 10.1021/jf960981s
14. Comparison of the pharmacokinetics of moxi-dectin (EQUEST) and ivermectin (EQVALAN) in horses. Perez, et al. JVPT 1999 22 174 180 10.1046/j.1365-2885. 1999.00200.x (Pubitemid 29363978)
15. Chemistry, Pharmacology and safety: Moxidectin. D Rock R DeLay M Gliddon, Macrocyclic Lactones in Antiparasitic Therapy, Vercruysse J, Rew R, Chapter 14 75 96
16. Absorption, Tissue Distribution, Metabolism and Excretion of Moxidectin in Cattle. J Zulalian S Stout A daCunha, et al. Journal of Agricultural and Food Chemistry 1997 42 381 387 10.1021/jf00038a028
17. Depletion of Moxidectin Tissue Residues in Sheep. A Lifschitz F Imperiale G Virkel M Mũoz Cobẽas N Scherling R DeLay C Lanusse, J Agric Food Chem 2000 48 6011 6015 10.1021/jf0000880 11141269
18. A multicenter evaluation of the effectiveness of QUEST Gel (2% moxidectin) against parasites infecting equids. R Cleale, et al. Vet Parasit 2006 137 119 129 10.1016/j.vetpar.2005.11.029 (Pubitemid 43384034)
19. Cyathostome fecal egg count trends in horses treated with moxidectin, ivermectin or fenbendazole. K Martin-Downum T Yazwinski C Tucker M Fincher J Ralph J Hamilton, Vet Parasit 2001 101 75 79 10.1016/S0304-4017(01)00495-2 (Pubitemid 32918320)
20. Dose titration of moxidectin oral gel against gastrointestinal parasites of ponies. CM Monahan MR Chapman DD French HW Taylor TR Klei, Vet Parasit 1995 59 241 248 10.1016/0304-4017(94)00762-2
21. Comparison of moxidectin oral gel and ivermectin oral paste against a spectrum of internal parasites of ponies with special attention to encysted cyathostome larvae. CM Monahan MR Chapman HW Taylor DD French TR Klei, Veterinary Parasit 1996 63 225 235 10.1016/0304-4017(95)00910-8 (Pubitemid 26198252)
22. Comparisons of Cyathostome Control and Selection for Benzimidazole Resistance Using Larvicidal Regimens of Moxidectin Gel or Fenbendazole Paste. CR Reinemeyer AW Farley BC Clymer, The International Journal of Applied Research 2003 1 1
23. Small strongyle infection: Consequences of larvicidal treatment of horses with fenbendazole and moxidectin. T Steinbach, et al. Veterinary Parasit 2006 139 115 131 10.1016/j.vetpar.2006.03.028 (Pubitemid 43775777)
24. Safety of oral moxidectin in breeding/pregnant mares and their unborn/newborn foals. J Kivipelto R Asquith J Harvey, Proceedings of the AAVP, 41st Annual Meeting 1996 Abstract No. 24
25. Field efficacy of moxidectin 2% equine gel (EQUEST) against gastrointestinal nematodes in mares with foals. C Mage, et al. Proceedings of the World Veterinary Congress 1999
26. Investigation of an outbreak of tapeworm-associated colic in a training yard. C Proudman N Holdstock, Equine Veterinary Journal 2000 32 37 41 11202380
27. Anoplocephala magna related to a case of equine acute abdomen. R Faleiros J Matos G Alves R Santos, Revista Brasileira de Medicina Veterinaria 2000 22 22 29
28. Post dosing colic and diarrhoea in horses with serological evidence of tapeworm. E Barret C Blair J Farlam C Proudman, Vet Rec 2005 156 252 253 15751572
29. Field evaluation of moxidectin/praziquantel oral gel in horses. ST Grubbs D Amodie D Rulli M Wulster-Radcliffe C Reinemeyer T Yazwinski C Tucker D Hutchens L Smith D Patterson, Veterinary therapeutics: research in applied veterinary medicine 2003 4 249 56 15136986
30. Adult tapeworms in horses: Clinical Significance. SE Little, Compend Contin Educ Pract Vet 1999 21 356 360
31. Evaluation of moxidectin and praziquantel, in a combined oral gel formulation, against nematodes and cestodes in horses. J Tolosa Palacios, 2001 FDAH Report GASD 08-01.01
32. Dung dispersal and grazing area following treatment of horses with a single dose of ivermectin. R Herd B Stinner F Purrington, Vet Parasitol 1993 48 229 240 10.1016/0304-4017(93)90158-J 8346636
33. Effects of moxidectin/praziquantel equine gel against dung non-target fauna when used at the recommended dose in horses. J Lumaret, 2004 FDAH Report GASD 09-50.00 14985782
34. Slowing the spread of anthelmintic resistant nematodes of horses in the United Kingdom. RP Herd GC Coles, VetRec 1995 136 481 485
35. Control strategies for ruminant and equine parasites to counter resistance, encystment and ecotoxicity in the USA. RP Herd, Vet Parasitol 1993 48 327 336 10.1016/0304-4017(93)90166-K 8346646
36. Apparent resistance of Parascaris equorum to macrocyclic lactones. JH Boersma M Eysker JW Nas, Vet Rec 2002 150 279 281 11924584
37. Identification of foals infected with Parascaris equorum apparently resistant to ivermectin. FP Hearn AS Peregrine, J Am Vet Med Assoc 2003 223 482 485 10.2460/javma.2003.223.482 12930086
38. Evidence if ivermectin resistance by Parascaris equorum on a Texas horse farm. TM Craig PL Diamond NS Ferwerda JA Thompson, J Eq Vet Sci 2007 27 67 71 10.1016/j.jevs.2006.12.002 (Pubitemid 46237707)
39. Macrocylic lactone-resistant Parascaris equorum on stud farms in Canada and effectiveness of fenbendazole and pyrantel pamoate. JOD Slocombe RVG de Gannes MC Lake, Vet Parasit 2007 145 3-4 371 376 10.1016/j.vetpar.2006.08.008 (Pubitemid 46454238)
40. Apparent ivermectin resistance of Parascaris equorum in foals in Denmark. H Schougard MK Nielsen, Vet Rec 2007 160 439 440 17400903
41. Parascaris equorum resistance to moxidectin? M Peaty, Vet Rec 2008 162 387 18359937
42. Field effectiveness of pyrantel and failure of Parascaris equorum egg count reduction following ivermectin treatment in Italian horse farms. F Veronese I Moretta A Moretti, Vet Parasitol 2009 161 138 141 10.1016/j.vetpar.2009.01.004 19201100
43. Anthelmintic resistance in Brazilian horses. M Molento J Antunes RN Bentes, Vet Rec 2008 162 384 385 18359933
44. Reduced efficacy of anthelmintics in young compared with adult horses. R Herd A Gabel, Equine Vet Journal 1990 22 164 169
45. Cases of reduced cyathostomin egg-reappearance period and failure of Parascaris equorum egg count reduction following ivermectin treatment as well as survey on pyrantel efficacy on German horse farms. G Von Samson-Himmelstjerna B Fritzen J Demeler S Schurmann K Rohn T Schneider C Epe, Vet Rec 2007 144 74 80
46. Ivermectin selection on beta-tubulin: Evidence in Onchocerca volvulus and Haemonchus contortus. JKL Eng WJ Blackhall MY Osei-Atweneboana C Bourguinat D Galazzo RN Beech TR Unnasch K Awadzi GW Lubega RK Prichard, Molecular & Biochemical Parasitology 2006 150 229 235 10.1016/j.molbiopara.2006.08.007 (Pubitemid 44773712)
47. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses. S Taylor J Kenny, Vet Rec 1995 137 516 518 8588278
48. Persistence of the efficacy of moxidectin gel on the establishment of cyathostominae in horses. J Vercruysse M Eysker D Demeulenaere K Smets P Dorny, Vet Rec 1998 143 307 309 9789349
49. Use of moxidectin and ivermectin in cyathostominae yearly control plan. Comparison of efficacy and persistency in naturally infected horses. F Solari Basano N Chierichetti C Genchi, Parassitologia 1998 40 168
50. The effect of ivermectin treatment against inhibited early third stage, late third stage and fourth stage larvae and adult stages of cyathostomes in Shetland ponies and spontaneous expulsion of these helminths. M Eysker J Boersma F Kooyman, Vet Parasitol 1992 42 295 302 10.1016/0304-4017(92)90071-G 1496789
51. Comparison of moxidectin oral gel and ivermectin paste against a spectrum of internal parasites of ponies with special attention to encysted cyathostome larvae. C Monahan M Chapman H Taylor D French T Klei, Vet Parasitol 1996 63 225 235 10.1016/0304-4017(95)00910-8 8966989
52. Evaluation of ivermectin at an elevated dose against encysted equine cyathostome larvae. TR Klei MR Chapman, Vet Parasitol 1993 47 99 106 10.1016/0304-4017(93)90180-U 8493773
53. Efficacy of oral ivermectin paste against mucosal stages of cyathostomes. S Love JL Duncan JM Parry WTR Grimshaw, Vet Rec 1995 136 18 19 7900257
54. A controlled trial evaluation of three oral dosages of moxidectin against equine parasites. TR Bello JET Laningham, J Equine Vet Sci 1994 14 9 483 488 10.1016/S0737-0806(06)81977-5
55. Selection for resistance to macrocyclic lactones in Haemonchus contortus in sheep. S Ranjan GT Wang C Hirschlein KL Simkins, Vet Par 2002 103 109 117 10.1016/S0304-4017(01)00551-9 (Pubitemid 34075247)
56. Characterization of two triple resistant field isolates of Teladorsagia from Scottish lowland sheep farms. DJ Bartley F Jackson N Sargison, Vet Par 2004 123 3-4 189 199 10.1016/j.vetpar.2004.06.018 (Pubitemid 39485928)
57. Efficacy of moxidectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. TM Craig TA Hatfield JA Pankavich GT Wang, Vet Par 1992 41 329 333 10.1016/0304-4017(92)90090-V
58. Moxidectin against ivermectin-resistant nematodes - a global view. P Kieran, AVJ 1994 71 1 18 20 10.1111/j.1751-0813.1994.tb00895.x
59. Efficacy of moxidectin, nemadectin and ivermectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. JA Pankavich H Berger KL Simkins, Vet Rec 1992 130 241 243 1514227
60. Decreased ivermectin and moxidectin sensitivity in Haemonchus contortus selected with moxidectin over 14 generations. MB Molento GT Wang RK Prichard, Vet Par 1999 86 77 81 10.1016/S0304-4017(99)00131-4 (Pubitemid 29387298)
61. Efficacy of moxidectin against an ivermectin-resistant strain of Ostertagia circumcincta in young sheep. WE Pomroy NC Whelan, Vet Rec 1993 132 416 8488663
62. Multiple resistance in goat-derived Ostertagia and the efficacy of moxidectin and combinations of other anthelmintics. WE Pomroy N Whelan AM Alexander DW West K Stafford BA Adlington SM Calder, NZVJ 1992 40 76 78
63. Studies on the mechanisms of action of moxidectin and ivermectin. R Prichard V Rao S Siddiqui C James S Forrester, Report on file 2009
64. Evidence of P-glycoprotein sequence diversity in cyathostomins. M Drogemuller T Schnieder G Von Samson-Himmelstjerna, Journal of Parasitology 2004 90 998 1003 10.1645/GE-3312 15562598